BCRX

BCRX R&D Expenses

$197.76MTTM · USD

Period ending:

BCRX FY R&D ExpensesUSD
BCRX FY R&D Expenses1994-12-31: $0.001995-12-31: $0.001996-12-31: $0.001997-12-31: $10.60M1998-12-31: $9.30M1999-12-31: $7.70M2000-12-31: $9.59M2001-12-31: $13.09M2002-12-31: $15.47M2003-12-31: $11.52M2004-12-31: $18.87M2005-12-31: $23.64M2006-12-31: $47.08M2007-12-31: $94.05M2008-12-31: $73.33M2009-12-31: $72.30M2010-12-31: $82.47M2011-12-31: $56.90M2012-12-31: $51.46M2013-12-31: $42.73M2014-12-31: $51.80M2015-12-31: $72.76M2016-12-31: $61.01M2017-12-31: $66.96M2018-12-31: $84.89M2019-12-31: $107.07M2020-12-31: $122.96M2021-12-31: $208.81M2022-12-31: $253.30M2023-12-31: $216.57M2024-12-31: $174.64M2025-12-31: $166.13M$253.30M$0.00
1994-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BCRX r&d expenses history

Research and development spending. The available annual fiscal periods series contains 32 observations from Dec 31, 1994 to Dec 31, 2025.

Biocryst Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
166,126,000
174,638,000
216,566,000
253,297,000
208,808,000
122,964,000
107,068,000
84,888,000
66,962,000
61,008,000
72,758,000
51,796,000
42,730,000
51,464,000
56,898,000
82,473,000
72,302,000
73,326,634
94,051,996
47,083,372
23,642,377
18,868,112
11,522,000
15,473,491
13,091,057
9,590,352
7,700,000
9,300,000
10,600,000
0
0
0

Compare r&d expenses

All BCRX financial metrics · BCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.